BMY
Price
$53.70
Change
+$0.43 (+0.81%)
Updated
Mar 28, 9:31 AM EST
28 days until earnings call
MRK
Price
$131.80
Change
+$6.26 (+4.99%)
Updated
Mar 27, 6:59 PM EST
28 days until earnings call
Ad is loading...

Compare trend and price BMY vs MRK

Header iconBMY vs MRK Comparison
Open Charts BMY vs MRKBanner chart's image
Bristol-Myers Squibb
Price$53.70
Change+$0.43 (+0.81%)
Volume$2.32K
CapitalizationN/A
Merck & Co
Price$131.80
Change+$6.26 (+4.99%)
Volume$5.14M
CapitalizationN/A
View a ticker or compare two or three
BMY vs MRK Comparison Chart

Loading...

BMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMY vs. MRK commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a StrongBuy and MRK is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (BMY: $53.25 vs. MRK: $131.75)
Brand notoriety: BMY and MRK are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 77% vs. MRK: 183%
Market capitalization -- BMY: $107.68B vs. MRK: $333.68B
BMY [@Pharmaceuticals: Major] is valued at $107.68B. MRK’s [@Pharmaceuticals: Major] market capitalization is $333.68B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.87B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whileMRK’s FA Score has 3 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, MRK is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 6 TA indicator(s) are bullish while MRK’s TA Score has 5 bullish TA indicator(s).

  • BMY’s TA Score: 6 bullish, 4 bearish.
  • MRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BMY is a better buy in the short-term than MRK.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а +2.64% price change this week, while MRK (@Pharmaceuticals: Major) price change was +6.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.60%. For the same industry, the average monthly price growth was -3.22%, and the average quarterly price growth was -2.05%.

Reported Earning Dates

BMY is expected to report earnings on Apr 25, 2024.

MRK is expected to report earnings on Apr 25, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+0.60% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for BMY with price predictions.
OPEN
A.I.dvisor published
a Summary for MRK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MRK($334B) has a higher market cap than BMY($108B). MRK has higher P/E ratio than BMY: MRK (941.07) vs BMY (13.80). MRK YTD gains are higher at: 21.616 vs. BMY (4.985). BMY has higher annual earnings (EBITDA): 19.4B vs. MRK (6.91B). BMY has more cash in the bank: 12.3B vs. MRK (7.09B). MRK has less debt than BMY: MRK (35.1B) vs BMY (41.5B). MRK has higher revenues than BMY: MRK (60.1B) vs BMY (45B).
BMYMRKBMY / MRK
Capitalization108B334B32%
EBITDA19.4B6.91B281%
Gain YTD4.98521.61623%
P/E Ratio13.80941.071%
Revenue45B60.1B75%
Total Cash12.3B7.09B173%
Total Debt41.5B35.1B118%
FUNDAMENTALS RATINGS
BMY vs MRK: Fundamental Ratings
BMY
MRK
OUTLOOK RATING
1..100
976
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
675
SMR RATING
1..100
3989
PRICE GROWTH RATING
1..100
5620
P/E GROWTH RATING
1..100
881
SEASONALITY SCORE
1..100
n/a38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (7) in the Pharmaceuticals Major industry is significantly better than the same rating for MRK (90). This means that BMY’s stock grew significantly faster than MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (67). This means that MRK’s stock grew somewhat faster than BMY’s over the last 12 months.

BMY's SMR Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for MRK (89). This means that BMY’s stock grew somewhat faster than MRK’s over the last 12 months.

MRK's Price Growth Rating (20) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (56). This means that MRK’s stock grew somewhat faster than BMY’s over the last 12 months.

MRK's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for BMY (88). This means that MRK’s stock grew significantly faster than BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYMRK
RSI
ODDS (%)
Bearish Trend 1 day ago
33%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
58%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
49%
MACD
ODDS (%)
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
50%
Declines
ODDS (%)
Bearish Trend 11 days ago
53%
Bearish Trend 15 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
41%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
46%
View a ticker or compare two or three
Ad is loading...
BMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MRKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPAD8.540.35
+4.27%
Offerpad Solutions
AEIS102.023.42
+3.47%
Advanced Energy Industries
VIVK0.800.02
+2.69%
Vivakor
SCVL35.790.85
+2.43%
Shoe Carnival
SE53.57-1.99
-3.58%
Sea Limited

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with NVS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then NVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+4.96%
NVS - MRK
44%
Loosely correlated
+0.64%
JNJ - MRK
44%
Loosely correlated
+1.41%
GSK - MRK
39%
Loosely correlated
+0.47%
AZN - MRK
37%
Loosely correlated
+2.89%
BMY - MRK
33%
Poorly correlated
+1.33%
More